Compare Piramal Healthcare with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs DR. DATSONS LABS - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES DR. DATSONS LABS PIRAMAL ENTERPRISES/
DR. DATSONS LABS
 
P/E (TTM) x 18.4 -10.9 - View Chart
P/BV x 1.2 0.2 721.2% View Chart
Dividend Yield % 1.5 0.0 -  

Financials

 PIRAMAL ENTERPRISES   DR. DATSONS LABS
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
DR. DATSONS LABS
Mar-14
PIRAMAL ENTERPRISES/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs3,303126 2,629.5%   
Low Rs1,79731 5,814.9%   
Sales per share (Unadj.) Rs716.5133.0 538.7%  
Earnings per share (Unadj.) Rs79.70.2 52,570.7%  
Cash flow per share (Unadj.) Rs107.96.6 1,633.0%  
Dividends per share (Unadj.) Rs28.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs1,477.5128.8 1,147.2%  
Shares outstanding (eoy) m184.4531.66 582.6%   
Bonus/Rights/Conversions ISFCCB-  
Price / Sales ratio x3.60.6 604.8%   
Avg P/E ratio x32.0516.1 6.2%  
P/CF ratio (eoy) x23.611.8 199.5%  
Price / Book Value ratio x1.70.6 284.0%  
Dividend payout %35.10-   
Avg Mkt Cap Rs m470,2922,477 18,983.3%   
No. of employees `0007.8NA-   
Total wages/salary Rs m22,50456 40,184.8%   
Avg. sales/employee Rs Th16,899.4NM-  
Avg. wages/employee Rs Th2,877.7NM-  
Avg. net profit/employee Rs Th1,879.9NM-  
INCOME DATA
Net Sales Rs m132,1534,211 3,138.7%  
Other income Rs m3,12879 3,974.6%   
Total revenues Rs m135,2814,289 3,154.0%   
Gross profit Rs m66,290569 11,658.4%  
Depreciation Rs m5,202204 2,544.8%   
Interest Rs m44,097430 10,250.4%   
Profit before tax Rs m20,11913 158,415.0%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,6116 141,168.9%   
Profit after tax Rs m14,7015 306,275.0%  
Gross profit margin %50.213.5 371.4%  
Effective tax rate %42.848.0 89.1%   
Net profit margin %11.10.1 9,758.1%  
BALANCE SHEET DATA
Current assets Rs m122,7426,852 1,791.4%   
Current liabilities Rs m310,8106,711 4,631.6%   
Net working cap to sales %-142.33.3 -4,249.6%  
Current ratio x0.41.0 38.7%  
Inventory Days Days23161 14.3%  
Debtors Days Days39318 12.2%  
Net fixed assets Rs m116,9043,673 3,182.8%   
Share capital Rs m369317 116.5%   
"Free" reserves Rs m272,1613,761 7,236.4%   
Net worth Rs m272,5304,078 6,683.8%   
Long term debt Rs m270,1961,671 16,171.7%   
Total assets Rs m856,26112,633 6,778.2%  
Interest coverage x1.51.0 141.4%   
Debt to equity ratio x1.00.4 242.0%  
Sales to assets ratio x0.20.3 46.3%   
Return on assets %6.93.4 199.4%  
Return on equity %5.40.1 4,582.4%  
Return on capital %12.47.7 161.9%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m15,200964 1,576.8%   
Fx outflow Rs m4,889607 805.3%   
Net fx Rs m10,312357 2,889.2%   
CASH FLOW
From Operations Rs m-115,9751,345 -8,623.9%  
From Investments Rs m-8,265-2,256 366.4%  
From Financial Activity Rs m107,525-1,200 -8,961.9%  
Net Cashflow Rs m-16,650-2,111 788.8%  

Share Holding

Indian Promoters % 52.9 4.5 1,167.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 0.0 -  
FIIs % 26.6 1.4 1,970.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 94.1 17.5%  
Shareholders   93,274 20,807 448.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   WOCKHARDT  J.B.CHEMICALS  ORCHID PHARMA LTD  DIVIS LABORATORIES  FULFORD INDIA  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Sep 20, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS